4//SEC Filing
Rhode Peter 4
Accession 0001209191-23-056086
CIK 0001828673other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 4:55 PM ET
Size
7.4 KB
Accession
0001209191-23-056086
Insider Transaction Report
Form 4
Rhode Peter
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2023-11-17$0.14/sh+15,000$2,100→ 63,500 total - Exercise/Conversion
Stock Option Grant (Right to Buy)
2023-11-17−15,000→ 36,427 totalExercise: $0.14Exp: 2029-12-19→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]These option shares were part of a stock option grant covering 85,713 shares of common stock. 20% of the total shares subject to the stock option grant vested on May 30, 2020; 20% of the total shares subject to the stock option grant vested on May 30, 2021; 25% of the total shares subject to the stock option grant vested on May 30, 2022; and 35% of the total shares subject to the stock option grant vested on May 30, 2023, subject to the reporting person's continuous service through the applicable vesting date.
Documents
Issuer
HCW Biologics Inc.
CIK 0001828673
Entity typeother
Related Parties
1- filerCIK 0001866276
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 4:55 PM ET
- Size
- 7.4 KB